Fig. 3: PRDX4 is associated with prognosis and clinical risk stratification in breast cancer bone metastasis. | npj Precision Oncology

Fig. 3: PRDX4 is associated with prognosis and clinical risk stratification in breast cancer bone metastasis.

From: Integrative multi-omics and machine learning framework identifies PRDX4 as a redox-EMT regulator and predictive marker in bone-metastatic breast cancer

Fig. 3

A Cox regression analysis forest plot. B Bar plot of PRDX4 expression. C Clinical information Sankey plot. D ROC plot of PRDX4. E Prognostic Nomogram and calibration plot of PRDX4. F Risk factor, KM plot, and time-dependent ROC plot of PRDX4. G DCA plot of PRDX4. Abbreviations: PRDX4, peroxiredoxin 4; ROC, receiver operating characteristic; KM, Kaplan–Meier; DCA, decision curve analysis.

Back to article page